LifeTech Scientific Corporation

DB:81X Stock Report

Market Cap: €805.1m

LifeTech Scientific Balance Sheet Health

Financial Health criteria checks 6/6

LifeTech Scientific has a total shareholder equity of CN¥3.4B and total debt of CN¥99.0M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are CN¥4.8B and CN¥1.4B respectively. LifeTech Scientific's EBIT is CN¥262.5M making its interest coverage ratio -16. It has cash and short-term investments of CN¥1.0B.

Key information

2.9%

Debt to equity ratio

CN¥99.00m

Debt

Interest coverage ratio-16x
CashCN¥1.04b
EquityCN¥3.39b
Total liabilitiesCN¥1.43b
Total assetsCN¥4.82b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 81X's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥826.5M).

Long Term Liabilities: 81X's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥602.8M).


Debt to Equity History and Analysis

Debt Level: 81X has more cash than its total debt.

Reducing Debt: 81X's debt to equity ratio has reduced from 22.7% to 2.9% over the past 5 years.

Debt Coverage: 81X's debt is well covered by operating cash flow (300.6%).

Interest Coverage: 81X earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies